The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment
Open accessAbstract
Peritoneal dialysis (PD)-associated peritonitis is a serious complication of PD and prevention and treatment of such is important in reducing patient morbidity and mortality. The ISPD 2022 updated recommendations have revised and clarified definitions for refractory peritonitis, relapsing peritonitis, peritonitis-associated catheter removal, PD-associated haemodialysis transfer, peritonitis-associated death and peritonitis-associated hospitalisation. New peritonitis categories and outcomes including pre-PD peritonitis, enteric peritonitis, catheter-related peritonitis and medical cure are defined. The new targets recommended for overall peritonitis rate should be no more than 0.40 episodes per year at risk and the percentage of patients free of peritonitis per unit time should be targeted at >80% per year. Revised recommendations regarding management of contamination of PD systems, antibiotic prophylaxis for invasive procedures and PD training and reassessment are included. New recommendations regarding management of modifiable peritonitis risk factors like domestic pets, hypokalaemia and histamine-2 receptor antagonists are highlighted. Updated recommendations regarding empirical antibiotic selection and dosage of antibiotics and also treatment of peritonitis due to specific microorganisms are made with new recommendation regarding adjunctive oral N-acetylcysteine therapy for mitigating aminoglycoside ototoxicity. Areas for future research in prevention and treatment of PD-related peritonitis are suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment
Li, P. K.-T., Szeto, C. C., Piraino, B., de Arteaga, J., Fan, S., Figueiredo, A. E., Fish, D. N., Goffin, E., Kim, Y.-L., Salzer, W., et al. (2016) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2016.00078 · Cited by 907
Self-citationPeritoneal Dialysis-Related Infections Recommendations: 2010 Update
Li, P. K.-T., Szeto, C. C., Piraino, B., Bernardini, J., Figueiredo, A. E., Gupta, A., Johnson, D. W., Kuijper, E. J., Lye, W.-C., Salzer, W., et al. (2010) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2010.00049 · Cited by 887
Self-citationPeritoneal Dialysis-Related Infections Recommendations: 2005 Update
Piraino, B., Bailie, G. R., Bernardini, J., Boeschoten, E., Gupta, A., Holmes, C., Kuijper, E. J., Li, P. K.-T., Lye, W.-C., Mujais, S., et al. (2005) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.1177/089686080502500203 · Cited by 700
Self-citationAdult Peritoneal Dialysis-Related Peritonitis Treatment Recommendations: 2000 Update
Keane, W. F., Bailie, G. R., Boeschoten, E., Gokal, R., Golper, T. A., Holmes, C. J., Kawaguchi, Y., Piraino, B., Riella, M., & Vas, S. (2000) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.1177/089686080002000406 · Cited by 410
Self-citationAntibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications
Iredell, J., Brown, J., & Tagg, K. (2016) · BMJ · doi:10.1136/bmj.h6420 · Cited by 392
Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update
Crabtree, J. H., Shrestha, B. M., Chow, K.-M., Figueiredo, A. E., Povlsen, J. V., Wilkie, M., Abdel-Aal, A., Cullis, B., Goh, B.-L., Briggs, V. R., et al. (2019) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2018.00232 · Cited by 323
Self-citationISPD Catheter-Related Infection Recommendations: 2017 Update
Szeto, C.-C., Li, P. K.-T., Johnson, D. W., Bernardini, J., Dong, J., Figueiredo, A. E., Ito, Y., Kazancioglu, R., Moraes, T., Van Esch, S., et al. (2017) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2016.00120 · Cited by 307
Self-citationWarady, B. A., Bakkaloglu, S., Newland, J., Cantwell, M., Verrina, E., Neu, A., Chadha, V., Yap, H.-K., & Schaefer, F. (2012) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2011.00091 · Cited by 272
Recent Peritonitis Associates with Mortality among Patients Treated with Peritoneal Dialysis
Boudville, N., Kemp, A., Clayton, P., Lim, W., Badve, S. V., Hawley, C. M., McDonald, S. P., Wiggins, K. J., Bannister, K. M., Brown, F. G., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121135 · Cited by 258
Self-citationPerl, J., Fuller, D. S., Bieber, B. A., Boudville, N., Kanjanabuch, T., Ito, Y., Nessim, S. J., Piraino, B. M., Pisoni, R. L., Robinson, B. M., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.09.016 · Cited by 238
Self-citationManera, K. E., Johnson, D. W., Craig, J. C., Shen, J. I., Gutman, T., Cho, Y., Wang, A. Y.-M., Brown, E. A., Brunier, G., Dong, J., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.09.017 · Cited by 204
Self-citationKeane, W. F., Alexander, S. R., Bailie, G. R., Boeschoten, E., Gokal, R., Golper, T. A., Holmes, C. J., Huang, C.-C., Kawaguchi, Y., Piraino, B., et al. (1996) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.1177/089686089601600606 · Cited by 202
Self-citationFungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes
Goldie, S. J., Kiernan-Troidle, L., Torres, C., Gorban-Brennan, N., Dunne, D., Kliger, A. S., & Finkelstein, F. O. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90135-3 · Cited by 189
Wang, A. Y. M., Yu, A. W. Y., Li, P. K. T., Lam, P. K. W., Leung, C. B., Lai, K. N., & Lui, S. F. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.19833 · Cited by 186
Self-citationPredictors and outcomes of fungal peritonitis in peritoneal dialysis patients
Miles, R., Hawley, C. M., McDonald, S. P., Brown, F. G., Rosman, J. B., Wiggins, K. J., Bannister, K. M., & Johnson, D. W. (2009) · Kidney International · doi:10.1038/ki.2009.202 · Cited by 162
Self-citationUpdate on Fungal Peritonitis and its Treatment
Matuszkiewicz‐Rowińska, J. (2009) · Peritoneal Dialysis International · doi:10.1177/089686080902902s31 · Cited by 161
Peleg, A. Y., & Abbott, I. J. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1396929 · Cited by 141
Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine
Feldman, L., Efrati, S., Eviatar, E., Abramsohn, R., Yarovoy, I., Gersch, E., Averbukh, Z., & Weissgarten, J. (2007) · Kidney International · doi:10.1038/sj.ki.5002295 · Cited by 136
van Diepen, A. T. N., TOMLINSON, G. A., & Jassal, S. V. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00980112 · Cited by 135
Bennett, P. N., Bohm, C. J., Harasemiw, O., Brown, L., Gabrys, I., Jegatheesan, D. K., Johnson, D. W., Lambert, K., Lightfoot, C. J., MacRae, J. M., et al. (2021) · Peritoneal Dialysis International · doi:10.1177/08968608211055290 · Cited by 120
Self-citationKo, J., Kang, C., Cornejo‐Juárez, P., Yeh, K., Wang, C.-H., Cho, S. Y., Gözel, M. G., Kim, S., Hsueh, P., Sekiya, N., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.008 · Cited by 118
Self-citationMcMullen, A. R., Anderson, N. W., Wallace, M. A., Shupe, A., & Burnham, C. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01111-17 · Cited by 108
Song, Y., Wu, J., Yan, H., & Chen, J. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr504 · Cited by 107
Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment
Abbott, I. J., Slavin, M. A., Turnidge, J. D., Thursky, K., & Worth, L. J. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.24 · Cited by 106
Hypokalemia in Chinese Peritoneal Dialysis Patients: Prevalence and Prognostic Implication
Szeto, C., Chow, K.-M., Kwan, B. C., Leung, C., Chung, K.-Y., Law, M.-C., & Li, P. K. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.03.015 · Cited by 104
Self-citationThodis, E. D., Vas, S. I., Bargman, J. M., Singhal, M. K., Chu, M., & Oreopoulos, D. G. (1998) · Peritoneal Dialysis International · doi:10.1177/089686089801800605 · Cited by 101
Empirical aminoglycosides for peritonitis do not affect residual renal function
Baker, R. J., Senior, H., Clemenger, M., & Brown, E. A. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50129 · Cited by 95
Hsueh, P., Badal, R. E., Hawser, S., Hoban, D. J., Bouchillon, S. K., Ni, Y., & Paterson, D. L. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.07.002 · Cited by 92
Zaruba, K., Peters, J., & Jungbluth, H. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80249-6 · Cited by 91
Antimicrobial resistance in nephrology
Wang, T. Z., Kodiyanplakkal, R. P., & Calfee, D. P. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0150-7 · Cited by 89
Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin
Kays, M. B., Overholser, B. R., Mueller, B. A., Moe, S. M., & Sowinski, K. M. (2003) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.08.027 · Cited by 86
Edey, M. M., Hawley, C. M., McDonald, S. P., Brown, F. G., Rosman, J. B., Wiggins, K. J., Bannister, K. M., & Johnson, D. W. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp641 · Cited by 84
Self-citationLortholary, O., Tod, M. M., Petitjean, O., & Cohen, Y. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30038-4 · Cited by 82
Zhang, J., Friberg, I. M., Kift-Morgan, A. P., Parekh, G., Morgan, M. P. G., Liuzzi, A. R., Lin, C., Donovan, K. L., Colmont, C. S., Morgan, P., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.01.017 · Cited by 80
Zacharioudakis, I. M., Zervou, F. N., Ziakas, P. D., Rice, L. B., & Mylonakis, E. E. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.016 · Cited by 77
Cotrimoxazole - optimal dosing in the critically ill
Brown, G. R. (2014) · Annals of Intensive Care · doi:10.1186/2110-5820-4-13 · Cited by 76
Valencia, C. A. R., Chacón, J. A., & Manjarrés, G. (2010) · Peritoneal Dialysis International · doi:10.3747/pdi.2008.00189 · Cited by 76
Kranzer, K., Elamin, W. F., Cox, H. S., Seddon, J. A., Ford, N. P., & Drobniewski, F. A. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207245 · Cited by 71
de Vin, F., Rutherford, P. A., & Faict, D. (2009) · Peritoneal Dialysis International · doi:10.1177/089686080902900101 · Cited by 67
Marshall, M. R. (2021) · Peritoneal Dialysis International · doi:10.1177/0896860821996096 · Cited by 65
Muthucumarana, K., Howson, P., Crawford, D., Burrows, S., Swaminathan, R., & Irish, A. B. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.05.003 · Cited by 64
Ribeiro, S. C., Figueiredo, A. E., Barretti, P., Pecoits‐Filho, R., & de Moraes, T. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127453 · Cited by 63
Self-citationDavies, S., Zhao, J., Morgenstern, H., Zee, J., Bieber, B. A., Fuller, D. S., Sloand, J. A., Vychytil, A., Kawanishi, H., Johnson, D. W., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.11.021 · Cited by 62
Self-citationLin, C., Roberts, G. W., Kift-Morgan, A., Donovan, K. L., Topley, N., & Eberl, M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013040332 · Cited by 60
Szeto, C., Chow, K., Wong, T. Y.-H., Leung, C., & Li, P. K. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01364-5 · Cited by 59
Self-citationProtection from ototoxicity of intraperitoneal gentamicin in guinea pig
Sinswat, P., Wu, W.-J., Sha, S.-H., & Schacht, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00437.x · Cited by 57
Peritoneal Dialysis–Associated Peritonitis: Suggestions for Management and Mistakes to Avoid
Sahlawi, M. A. A., Bargman, J. M., & Perl, J. M. (2020) · Kidney Medicine · doi:10.1016/j.xkme.2020.04.010 · Cited by 57
Self-citationJunco, S. J., Bowman, M. C., & Turner, R. B. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106367 · Cited by 57
Nochaiwong, S., Ruengorn, C., Koyratkoson, K., Thavorn, K., Awiphan, R., Chaisai, C., Phatthanasobhon, S., Noppakun, K., Suteeka, Y., Panyathong, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33196-2 · Cited by 55
Characteristics and Outcomes of Fungal Peritonitis in a Modern North American Cohort
Nadeau‐Fredette, A., & Bargman, J. M. (2014) · Peritoneal Dialysis International · doi:10.3747/pdi.2013.00179 · Cited by 53
Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients
Peng, L. W., & Lien, Y.-H. H. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.09.017 · Cited by 49
Sankar, A., Swanson, K. M., Zhou, J., Jena, A. B., Ross, J. S., Shah, N. D., & Karaca‐Mandic, P. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.36662 · Cited by 48
Effects of Lanthanum Carbonate on the Absorption and Oral Bioavailability of Ciprofloxacin
How, P., Fischer, J. H., Arruda, J. A. L., et al. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580407 · Cited by 47
Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance
Gioia, F., Gómez‐López, A., Alvarez, M. E., de la Pedrosa, E. G., Martín‐Dávila, P., Cuenca‐Estrella, M., Moreno, S., & Fortün, J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.019 · Cited by 47
Shalit, I., Greenwood, R. B., Marks, M. I., Pederson, J. A., & Frederick, D. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.1.152 · Cited by 44
Pets-Related Peritonitis in Peritoneal Dialysis: Companion Animals or Trojan Horses?
Broughton, A., Verger, C., & Goffin, E. J. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00726.x · Cited by 43
Giacobino, J., Montelli, A. C., Barretti, P., Bruder-Nascimento, A., Caramori, J. C. T., Barbosa, L., & Bagagli, E. (2016) · Medical Mycology · doi:10.1093/mmy/myw030 · Cited by 41
Goodlad, C., George, S., Sandoval, S., Mepham, S., Parekh, G., Eberl, M., Topley, N., & Davenport, A. (2020) · Kidney International · doi:10.1016/j.kint.2020.01.044 · Cited by 41
Non-tuberculous mycobacterial PD peritonitis in Australia
Jiang, S., Roberts, D. M., Clayton, P. A., & Jardine, M. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0328-4 · Cited by 40
Sahlawi, M. A. A., Wilson, G., Stallard, B., et al. (2020) · Peritoneal Dialysis International · doi:10.1177/0896860819893810 · Cited by 39
Worasilchai, N., Leelahavanichkul, A., Kanjanabuch, T., Thongbor, N., Lorvinitnun, P., Sukhontasing, K., Finkelman, M., & Chindamporn, A. (2015) · Medical Mycology · doi:10.1093/mmy/myv007 · Cited by 37
Self-citationHughes, S., Gilchrist, M. J., Heard, K. L., Hamilton, R. A., & Sneddon, J. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa075 · Cited by 36
The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species
Szeto, C., Chow, K., Chung, K.-Y., Kwan, B. C., Leung, C., & Li, P. K. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi123 · Cited by 35
Self-citationVerma, A., Chitalia, V. C., Waikar, S. S., & Kolachalama, V. B. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2021.04.012 · Cited by 34
Wong, P.-N., Lo, K., Tong, G. M. W., Chan, S., Lo, M., Mak, S., & Wong, A. K. (2008) · Peritoneal Dialysis International · doi:10.1177/089686080802800211 · Cited by 33
Viridans Streptococci in Peritoneal Dialysis Peritonitis: Clinical Courses and Long-Term Outcomes
Chao, C., Lee, S., Yang, W., Chen, H., Fang, C., Yen, C., Chiang, C., Hung, K., & Huang, J. (2014) · Peritoneal Dialysis International · doi:10.3747/pdi.2013.00108 · Cited by 32
Cardone, K. E., Lodise, T. P., Patel, N., Hoy, C. D., Meola, S., Manley, H. J., Drusano, G. L., & Grabe, D. W. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08510910 · Cited by 32
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy
Lam, E., Lien, Y. T., Kraft, W., Piraino, B., Vozmediano, V., Schmidt, S., & Zhang, J. (2020) · Peritoneal Dialysis International · doi:10.1177/0896860819889774 · Cited by 31
Self-citationRegular Lactulose use is Associated with Lower Peritonitis Rates: An Observational Study
Afşar, B., Elsürer, R., Bilgiç, M. A., Sezer, S., & Özdemir, F. N. (2010) · Peritoneal Dialysis International · doi:10.3747/pdi.2009.00035 · Cited by 30
Aminoglycoside ototoxicity in pediatric patients receiving long-term peritoneal dialysis
Warady, B. A., Reed, L., Murphy, G., Kastetter, S., Karlsen, E. A., Alon, U. S., & Hellerstein, S. (1993) · Pediatric Nephrology · doi:10.1007/bf00864390 · Cited by 29
Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients
Maeda, S., Yamaguchi, M., Maeda, K., Kobayashi, N., Izumi, N., Nagai, M., Obayashi, T., Ohashi, W., Katsuno, T., Nobata, H., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224859 · Cited by 29
Zhong, H., Lin, D., Lü, Z.-Y., Yang, W., & Chen, Y. (2018) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12769 · Cited by 27
Pharmacokinetics of Intraperitoneal Fluconazole during Continuous Cycling Peritoneal Dialysis
Dahl, N. V., Foote, E. F., Searson, K. M., Fein, J. L., Kapoian, T., Steward, C. A., & Sherman, R. A. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.18152 · Cited by 26
Aspergillus peritonitis in peritoneal dialysis patients: A systematic review
Dotis, J., Kondou, A., Koukloumperi, E., Karava, V., Papadopoulou, A., Gkogka, C., & Printza, N. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101037 · Cited by 26
The Role of Monitoring Vancomycin Levels in Patients with Peritoneal Dialysis-Associated Peritonitis
Stevenson, S. J., Tang, W., Cho, Y., Mudge, D. W., Hawley, C. M., Badve, S. V., & Johnson, D. W. (2014) · Peritoneal Dialysis International · doi:10.3747/pdi.2013.00156 · Cited by 25
Self-citationSerna, J. H., Wanger, A. R., & Dosekun, A. K. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00797-2 · Cited by 24
Prasad, J. M., Negrón, O. A., Du, X., Mullins, E. S., Palumbo, J. S., Gilbertie, J. M., Höök, M., Grover, S. P., Pawliński, R., Mackman, N., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009837118 · Cited by 22
Fontán, M. P., Lopes, D. M., Enríquez, A. G., López‐Calviño, B., López–Muñiz, A., Falcón, T. G., & Rodríguez–Carmona, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148806 · Cited by 18
Kitrungphaiboon, T., Puapatanakul, P., Chuengsaman, P., Tiskajornsiri, K., Halue, G., Siribamrungwong, M., Matayart, S., Chongthanakorn, K., Poonvivatchaikarn, U., Boonyakrai, C., et al. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.05.011 · Cited by 18
Self-citationSzeto, C., Ng, J. K., Chow, K. M., Kwan, B. C., Kwong, V. W.-K., Law, M.-C., Leung, C. B., & Li, P. K.-T. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000484426 · Cited by 17
Self-citationMycobacterium tuberculosis peritonitis in peritoneal dialysis patients: A scoping review
Thomson, A. B. R., Vaughan, S. D., & Momciu, B. (2021) · Nephrology · doi:10.1111/nep.13997 · Cited by 16
Dias, R. C. B., Vieira, M. A., dos Santos, A. C. M. L., Riboli, D. F. M., Monteiro, A. C. M., Camargo, C. H., Tiba‐Casas, M. R., Soares, F. B., dos Santos, L. F., Montelli, A. C., et al. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001043 · Cited by 15
Ling, C. W., Sud, K., Van, C., et al. (2021) · Peritoneal Dialysis International · doi:10.1177/0896860821990528 · Cited by 11
Gastroscopy-Related Peritonitis in Peritoneal Dialysis Patients
Nadeau‐Fredette, A., & Bargman, J. M. (2014) · Peritoneal Dialysis International · doi:10.3747/pdi.2012.00340 · Cited by 10
Beredaki, M.-I., Arendrup, M. C., Andes, D. R., Mouton, J. W., & Meletiadis, J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01292-20 · Cited by 10
Effect of peritoneal dialysis fluids on activity of echinocandins against Candida spp. biofilm
Tobudic, S., Harrison, N. M., Forstner, C., Kussmann, M., & Burgmann, H. (2017) · Medical Mycology · doi:10.1093/mmy/myw145 · Cited by 9
Chamroensakchai, T., Manuprasert, W., Leelahavanichkul, A., Takkavatakarn, K., Thongbor, N., Jaroenpattrawut, B., & Kanjanabuch, T. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1642-1 · Cited by 6
Self-citationPeritoneal Dialysis Associated Peritonitis Rate – Validation of a Simplified Formula
Marshall, M. R., Waters, G. P., & Verger, C. (2021) · Bulletin de la Dialyse à Domicile · doi:10.25796/bdd.v4i4.63443 · Cited by 6
Nzana, V. B., Rohit, A., George, D., Vijayan, M., Mathew, M., Sankaran, S., Nagarajan, P., & Abraham, G. (2018) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_18_225 · Cited by 5
Candida glabrata PD-Associated Peritonitis: A Case Report
Emami, S., & Lew, S. Q. (2018) · Peritoneal Dialysis International · doi:10.3747/pdi.2018.00044 · Cited by 2
Cited by
Epidemiology of peritoneal dialysis outcomes
Bello, A. K., Okpechi, I. G., Osman, M. A., Cho, Y., Cullis, B., Htay, H., Jha, V., Makusidi, M. A., McCulloch, M., Shah, N., et al. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00623-7 · Cited by 264
Self-citation
Metadata
- Authors
- Li, P. K.-T., Chow, K. M., Cho, Y., Fan, S., Figueiredo, A. E., Harris, T., Kanjanabuch, T., Kim, Y.-L., Madero, M., Malyszko, J., Mehrotra, R., Okpechi, I. G., Perl, J., Piraino, B., Runnegar, N., Teitelbaum, I., Wong, J. K.-W., Yu, X., & Johnson, D. W.
- Venue
- Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Publisher
- SAGE Publications
- Published
- 2022-03
- Volume
- 42
- Issue
- 2
- Pages
- 110-153
- ISSN
- 0896-8608 (ISSN-L)
- 1718-4304
- OpenAlex
- W4220978627
- Cited by
- 701
- References
- 91
- FWCI
- 72.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.